Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Rebus Holdings, Inc. (NSPX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
03/31/2023 10-K Annual Report for the period ended December 31, 2022
01/10/2023 SC 13G/A SABBY MANAGEMENT, LLC reports a 0% stake in Rebus Holdings, Inc.
11/21/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/16/2022 8-K Quarterly results
11/14/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
10/13/2022 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
05/13/2022 10-Q Quarterly Report for the period ended March 31, 2022
03/31/2022 10-K Annual Report for the period ended December 31, 2021
12/10/2021 EFFECT Form EFFECT - Notice of Effectiveness:
12/09/2021 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
12/03/2021 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
11/12/2021 10-Q Quarterly Report for the period ended September 30, 2021
10/12/2021 8-K/A Other Events  Interactive Data
10/12/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Inspyr Therapeutics Announces New Holding Company Structure and Reverse Stock Split WESTLAKE VILLAGE, CA, October 12, 2021 – Inspyr Therapeutics, Inc. is announcing a 1-for-75 reverse stock split of its common stock and a holding company restructuring whereby Rebus Holdings, Inc. , a newly created entity will serve as the new holding company that will replace Inspyr as the public company trading on the OTC Markets trading under the symbol RBSH. The reverse stock split and holding company reorganization will occur concurrently. Inspyr has completed a restructuring consisting of reacquiring its rights to its now lead asset RT-AR001 and transforming into a holding company structure. Management believes that reacquiring the Adenosine assets and its new structure will lead to a more streamlined..."
09/03/2021 DEF 14C Form DEF 14C - Other definitive information statements:
08/25/2021 PRE 14C Form PRE 14C - Other preliminary information statements:
08/16/2021 10-Q Quarterly Report for the period ended June 30, 2021
07/07/2021 D Form D - Notice of Exempt Offering of Securities:
06/21/2021 8-K Quarterly results
05/17/2021 10-Q Quarterly Report for the period ended March 31, 2021
04/29/2021 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
04/01/2021 8-K Quarterly results
03/31/2021 10-K Annual Report for the period ended December 31, 2020
02/02/2021 D Form D - Notice of Exempt Offering of Securities:
02/02/2021 D Form D - Notice of Exempt Offering of Securities:
02/02/2021 D Form D - Notice of Exempt Offering of Securities:
01/12/2021 8-K Quarterly results
11/27/2020 8-K Quarterly results
11/20/2020 10-Q Quarterly Report for the period ended September 30, 2020
11/16/2020 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy